Ensysce Biosciences files 8-K/A
- Includes audited financials of Cy Biopharma for 2025 and 2024
- Unaudited financials for six months ended June 30, 2026
- Pro forma financials for 2026 and 2025 included
Every EDGAR filing for Ensysce Biosciences, Inc. (ENSC), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 13 · 10-Q expected ~Nov 13 (deadline Nov 16)
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Ownership stake disclosure by Bob G Gower (amended)
Bob G Gower, filed by
Bob G Gower, insider filing for ENSCW
Bob G Gower, reporting
James William Morrison, new insider at ENSCW
James William Morrison, reporting